Elizabeth A. Musgrove

Active 1983–2021

69
Papers
22,459
Citations
66
h-index
69
i10-index

Citations

Citations per year for Elizabeth A. Musgrove1984: 8 citations1985: 7 citations1986: 14 citations1987: 20 citations1988: 20 citations1989: 30 citations1990: 30 citations1991: 27 citations1992: 19 citations1993: 29 citations1994: 55 citations1995: 47 citations1996: 50 citations1997: 86 citations1998: 118 citations1999: 103 citations2000: 95 citations2001: 107 citations2002: 84 citations2003: 119 citations2004: 154 citations2005: 136 citations2006: 123 citations2007: 89 citations2008: 84 citations2009: 90 citations2010: 123 citations2011: 142 citations2012: 138 citations2013: 123 citations2014: 146 citations2015: 150 citations2016: 206 citations2017: 287 citations2018: 306 citations2019: 815 citations2020: 886 citations2021: 822 citations2022: 611 citations2023: 391 citations2024: 552 citations2025: 272 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,728 citing papers, 28.3% of this breakdownChina: 1,067 citing papers, 11% of this breakdownUnited Kingdom: 690 citing papers, 7.1% of this breakdownGermany: 566 citing papers, 5.9% of this breakdownItaly: 515 citing papers, 5.3% of this breakdownAustralia: 393 citing papers, 4.1% of this breakdownJapan: 334 citing papers, 3.5% of this breakdownCanada: 329 citing papers, 3.4% of this breakdownFrance: 326 citing papers, 3.4% of this breakdownNetherlands: 267 citing papers, 2.8% of this breakdownSpain: 264 citing papers, 2.7% of this breakdownSwitzerland: 163 citing papers, 1.7% of this breakdown
0%28.3%Other 20.8%

Fields

  • Medicine53.3%
  • Biochemistry, Genetics and Molecular Biology41.1%
  • Immunology and Microbiology2%
  • Computer Science0.6%
  • Agricultural and Biological Sciences0.5%
  • Neuroscience0.4%
  • Other2.1%

Topics

  • Pancreatic and Hepatic Oncology Research9.6%
  • Cancer Genomics and Diagnostics5.2%
  • Cancer-related Molecular Pathways4.7%
  • Epigenetics and DNA Methylation3.1%
  • Estrogen and related hormone effects2.8%
  • Cancer Cells and Metastasis2.7%
  • Other71.9%

Coauthors

All papers

Open in search
  1. Genomic analyses identify molecular subtypes of pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Darrin F. Taylor, Kelly Quek, Alan J. Robertson, Lorena Pantano, Laura Mincarelli, Luis Navarro-Sánchez, Lisa Evers, Jianmin Wu, Mark Pinese, Mark J. Cowley, Marc D. Jones, Emily K. Colvin, Adnan M. Nagrial, Emily S. Humphrey, Lorraine A. Chantrill, Amanda Mawson, Jeremy L. Humphris, Angela Chou, Marina Pajic, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Lovell, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Kim Moran‐Jones, Nigel B. Jamieson, Janet Graham, Fraser R. Duthie, Karin A. Oien, Jane Hair, Robert Grützmann, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Borislav C. Rusev, Paola Capelli, Roberto Salvia, Giampaolo Tortora, Debabrata Mukhopadhyay, Gloria M. Petersen, Australian Pancreatic Cancer Genome Initiative, Donna M. Munzy, William E. Fisher, Saadia A. Karim, James R. Eshleman, Ralph H. Hruban, Christian Pilarsky, Jennifer P. Morton, Owen J. Sansom, Aldo Scarpa, Elizabeth A. Musgrove, Ulla‐Maja Bailey, Oliver Hofmann, Robert L. Sutherland, David A. Wheeler, Anthony J. Gill, Richard A. Gibbs, John V. Pearson and 3 more - Nature 2016 cited by 3,775

  2. Whole genomes redefine the mutational landscape of pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felicity Newell, Barsha Poudel, Sarah Song, Darrin F. Taylor, Nick M. Waddell, Scott Wood, Qinying Xu, Jianmin Wu, Mark Pinese, Mark J. Cowley, Hong C. Lee, Marc D. Jones, Adnan Nagrial, Jeremy L. Humphris, Lorraine A. Chantrill, Venessa Chin, Angela Steinmann, Amanda Mawson, Emily S. Humphrey, Emily K. Colvin, Angela Chou, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Pettitt, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Nigel B. Jamieson, Janet Graham, Simone P. Niclou, Rolf Bjerkvig, Robert Grützmann, Daniela E. Aust, Ralph H. Hruban, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Massimo Falconi, Giuseppe Zamboni, Giampaolo Tortora, Margaret A. Tempero, Anthony J. Gill, James R. Eshleman, Christian Pilarsky, Aldo Scarpa, Elizabeth A. Musgrove, John V. Pearson, Andrew V. Biankin, Sean M. Grimmond - Nature 2015 cited by 2,709

  3. Whole-genome landscape of pancreatic neuroendocrine tumours

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felicity Newell, Nick M. Waddell, Oliver Holmes, Stephen H. Kazakoff, Conrad Leonard, Scott Wood, Qinying Xu, Shivashankar H. Nagaraj, Eliana Amato, Irene Dalai, Samantha Bersani, Ivana Cataldo, Angelo Paolo Dei Tos, Paola Capelli, Maria Vittoria Davì, Luca Landoni, Anna Malpaga, Marco Miotto, Vicki Whitehall, Barbara Leggett, Janelle L. Harris, Jonathan M. Harris, Marc D. Jones, Jeremy L. Humphris, Lorraine A. Chantrill, Venessa Chin, Adnan Nagrial, Marina Pajic, Christopher J. Scarlett, Andreia V. Pinho, Ilse Rooman, Christopher W. Toon, Jianmin Wu, Mark Pinese, Mark J. Cowley, Andrew P. Barbour, Amanda Mawson, Emily S. Humphrey, Emily K. Colvin, Angela Chou, Jessica A. Lovell, Nigel B. Jamieson, Fraser R. Duthie, Marie‐Claude Gingras, William E. Fisher, Rebecca A. Dagg, Loretta M. S. Lau, Michael Lee, Hilda A. Pickett, Roger R. Reddel, Jaswinder S. Samra, James G. Kench, Neil D. Merrett, Krishna Epari, Nam Q. Nguyen, Nikolajs Zeps, Massimo Falconi, Michele Simbolo, Giovanni Butturini, George Van Buren, Stefano Partelli, Matteo Fassan, Kum Kum Khanna, Anthony J. Gill, David A. Wheeler, Richard A. Gibbs, Elizabeth A. Musgrove, Claudio Bassi, Giampaolo Tortora, Paolo Pederzoli and 4 more - Nature 2017 cited by 1,025

  4. Cyclin D as a therapeutic target in cancer

    Authors: , , , , - Nature reviews. Cancer 2011 cited by 1,367

  5. Biological determinants of endocrine resistance in breast cancer

    Authors: , - Nature reviews. Cancer 2009 cited by 1,259

  6. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frances R. Balkwill, Simon T. Barry, Robert Grützmann, Lola Rahib, Sarah Allison, Peter J. Bailey, Ulla‐Maja Bailey, Andrew V. Biankin, Dario Beraldi, Holly Brunton, Giuseppina Caligiuri, Euan Cameron, David K. Chang, Susanna L. Cooke, Richard Cunningham, Stephan B. Dreyer, Paul Grimwood, Shane Kelly, Eirini-Maria Lampraki, John L. Marshall, Sancha Martin, Brian McDade, Daniel L. McElroy, Elizabeth A. Musgrove, Craig Nourse, Viola Paulus-Hock, Donna Ramsay, Rosie Upstill-Goddard, Derek Wright, Marc D. Jones, Lisa Evers, Selma Rebus, Lola Rahib, Bryan Serrels, Jane Hair, Nigel B. Jamieson, Colin J. McKay, Paul Westwood, Nicola Williams, Fraser Duthie, Andrew V. Biankin, Amber L. Johns, Amanda Mawson, David K. Chang, Christopher J. Scarlett, Mary-Anne L. Brancato, Sarah J. Rowe, Skye H. Simpson, Mona Martyn-Smith, Michelle T. Thomas, Lorraine A. Chantrill, Venessa Chin, Angela Chou, Mark J. Cowley, Jeremy L. Humphris, Marc D. Jones, R. Scott Mead, Adnan M. Nagrial, Marina Pajic, Jessica Pettit, Mark Pinese, Ilse Rooman, Jianmin Wu, Tao Jiang, Renee DiPietro, Clare Watson, Angela Steinmann, Hong Ching Lee, Rachel Wong, Andreia V. Pinho and 146 more - Gastroenterology 2020 cited by 173

  7. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susanna L. Cooke, Stephan B. Dreyer, Paul Grimwood, Shane Kelly, John L. Marshall, Brian McDade, Daniel L. McElroy, Donna Ramsay, Rosanna Upstill‐Goddard, Selma Rebus, Jane Hair, Nigel B. Jamieson, Colin J. McKay, Paul Westwood, Nicola Williams, Fraser R. Duthie, Andrew V. Biankin, Amber L. Johns, Amanda Mawson, David K. Chang, Christopher J. Scarlett, Mary-Anne L. Brancato, Sarah J. Rowe, Skye H. Simpson, Mona Martyn-Smith, Michelle T. Thomas, Lorraine A. Chantrill, Venessa Chin, Angela Chou, Mark J. Cowley, Jeremy L. Humphris, R. Scott Mead, Adnan Nagrial, Marina Pajic, Jessica Pettit, Mark Pinese, Ilse Rooman, Jianmin Wu, Tao Jiang, Renee DiPietro, Clare Watson, Angela Steinmann, Hong Ching Lee, Rachel Wong, Andreia V. Pinho, Marc Giry-Laterrière, Roger J. Daly, Elizabeth A. Musgrove, Robert L. Sutherland, Sean M. Grimmond, Nicola Waddell, Karin S. Kassahn, David K. Miller, Peter J. Wilson, Ann-Marie Patch, Sarah Song, Ivon Harliwong, Senel Idrisoglu, Ehsan Nourbakhsh, Suzanne Manning, Shivangi Wani, Milena Gongora, Matthew J. Anderson, Oliver Holmes, Conrad Leonard, Darrin F. Taylor, Scott Wood, Christina Xu, Kátia Nones, J. Lynn Fink and 105 more - Cell Reports 2020 cited by 127

  8. The prognostic and predictive value of serum CA19.9 in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , - Annals of Oncology 2012 cited by 304

  9. Hypermutation In Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianmin Wu, Mark Pinese, Mark J. Cowley, Marc D. Jones, Adnan Nagrial, Venessa Chin, Lorraine A. Chantrill, Amanda Mawson, Angela Chou, Christopher J. Scarlett, Andreia V. Pinho, Ilse Rooman, Marc Giry-Laterrière, Jaswinder S. Samra, James G. Kench, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Nigel B. Jamieson, Colin J. McKay, C Ross Carter, Euan J. Dickson, Janet Graham, Fraser R. Duthie, Karin A. Oien, Jane Hair, Jennifer P. Morton, Owen J. Sansom, Robert Grützmann, Ralph H. Hruban, Anirban Maitra, Christine A. Iacobuzio–Donahue, Richard D. Schulick, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Borislav C. Rusev, Vincenzo Corbo, Roberto Salvia, Ivana Cataldo, Giampaolo Tortora, Margaret A. Tempero, Oliver Hofmann, James R. Eshleman, Christian Pilarsky, Aldo Scarpa, Elizabeth A. Musgrove, Anthony J. Gill, John V. Pearson, Sean M. Grimmond, Nicola Waddell, Andrew V. Biankin - Gastroenterology 2016 cited by 208

  10. Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

    Authors: , , , , , , , , , , , , , , - Molecular Cancer Therapeutics 2012 cited by 154

  11. DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer

    Authors: , , , , , , , , , , , , - Nature Communications 2015 cited by 134

  12. Clinical and molecular characterization of HER2amplified-pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Genome Medicine 2013 cited by 119

  13. Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2

    Authors: , , , , - Journal of Biological Chemistry 1997 cited by 447

  14. Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2011 cited by 169

  15. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amber L. Johns, Anthony J. Gill, Lorraine A. Chantrill, Paul Timpson, Angela Chou, Marina Pajic, Tanya Dwarte, David Herrmann, Claire Vennin, Thomas R. Cox, Brooke Pereira, Shona Ritchiee, Daniel A. Reed, Cecilia R. Chambers, Xanthe L. Metcalf, Max Nobis, Gloria Jeong, Lara Kenyon, Ruth J. Lyons, Nicola Waddell, John V. Pearson, Ann‐Marie Patch, Kátia Nones, Felicity Newell, Pamela Mukhopadhyay, Venkateswar Addala, Stephen H. Kazakoff, Oliver Holmes, Conrad Leonard, Scott Wood, Sean M. Grimmond, Oliver Hofmann, Jaswinder S. Samra, Nick Pavlakis, Jennifer Arena, Hilda A. High, Ray Asghari, Neil D. Merrett, Amitabha Das, Peter H. Cosman, Kasim Ismail, Alina Stoita, David Williams, Allan Spigellman, Duncan McLeod, Judy Kirk, James G. Kench, Peter Grimison, Charbel Sandroussi, Annabel Goodwin, R. Scott Mead, Katherine Tucker, Lesley Andrews, Michael Texler, Cindy Forrest, Mo Ballal, David Fletcher, Maria Beilin, Kynan Feeney, Krishna Epari, Sanjay Mukhedkar, Nikolajs Zeps, Nan Q. Nguyen, Andrew Ruszkiewicz, Chris Worthley, John Chen, Mark E. Brooke‐Smith, Virginia Papangelis, Andrew D. Clouston, Andrew P. Barbour and 21 more - Gastroenterology 2021 cited by 46

  16. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lola Rahib, Australian Pancreatic Cancer Genome Initiative, Amber L. Johns, Marina Pajic, Fieke E. M. Froeling, Phillip Beer, Elizabeth A. Musgrove, Gloria M. Petersen, Alan Ashworth, Margaret C. Frame, Howard C. Crawford, Diane M. Simeone, Christopher J. Lord, Debabrata Mukhopadhyay, Christian Pilarsky, Susanna L. Cooke, Nigel B. Jamieson, Jennifer P. Morton, Owen J. Sansom, Peter J. Bailey, Andrew V. Biankin, David K. Chang - 2019 cited by 19

  17. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

    Authors: , , , , , - Endocrine Related Cancer 2003 cited by 336

  18. PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality

    Authors: , , , , , , , , - International Journal of Cancer 2009 cited by 304

  19. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

    Authors: , , , , , , , - 1999 cited by 217

  20. c-Myc overexpression and endocrine resistance in breast cancer

    Authors: , , , , , , , , , , , , , , , - The Journal of Steroid Biochemistry and Molecular Biology 2006 cited by 88

  21. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 378

  22. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E

    Authors: , , , - Endocrine Related Cancer 2005 cited by 244

  23. Cell cycle control in breast cancer cells

    Authors: , , , - Journal of Cellular Biochemistry 2005 cited by 235

  24. Cyclins: Roles in mitogenic signaling and oncogenic transformation

    Authors: - Growth Factors 2006 cited by 152